![Constantine Chinoporos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Constantine Chinoporos
Direktor/Vorstandsmitglied bei
GERON CORPORATION
Profil
Constantine Chinoporos is currently Director at Halozyme Hypercon, Inc. and will be Director at Geron Corp.
starting in 2026.
Formerly, Mr. Chinoporos was Chief Business Officer at Boston Pharmaceuticals, Inc. from 2015 to 2021, Chief Business Officer at Albireo Pharma, Inc. from 2021 to 2023, Chief Operating & Business Officer at Applied Therapeutics, Inc. from 2023 to 2026, and Head-Corporate Development at Genzyme Corp.
Education includes an undergraduate degree from Cornell University and an MBA from Johnson Graduate School of Management.
Aktive Positionen von Constantine Chinoporos
| Unternehmen | Position | Beginn |
|---|---|---|
| GERON CORPORATION | Direktor/Vorstandsmitglied | 25.03.2026 |
Elektrofi, Inc.
 Elektrofi, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company with a breakthrough ultra-high concentration microparticle technology for biologics | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Constantine Chinoporos
| Unternehmen | Position | Ende |
|---|---|---|
| APPLIED THERAPEUTICS, INC. | Geschäftsführer | 03.02.2026 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 01.03.2023 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Corporate Officer/Principal | 01.10.2021 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Ausbildung von Constantine Chinoporos
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Commercial Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Applied Therapeutics, Inc.
 Applied Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative drugs and technologies for debilitating diseases | Health Technology |
Elektrofi, Inc.
Elektrofi, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company with a breakthrough ultra-high concentration microparticle technology for biologics | Commercial Services |
